ProQR Therapeutics NV (PRQR) Stock Price, Quote, News & History

PRQRNASDAQ
$1.72
0.0150.88%
Last update: Jul 14, 1:53 PM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-48.14M
Investing Cash Flow (TTM)
-960.00K
Financing Cash Flow (TTM)
-1.64M
Free Cash Flow (TTM)
-49.10M
Capital Expenditure (TTM)
-960.00K
Net Change in Cash (TTM)
-50.74M

Analyst Trends and Forecast

1
Apr
3
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$164.07M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
11.65
PB Ratio (TTM)
5.57
Earnings Yield % (TTM)
-28.98%
Earnings Yield % (FWD)
-30.98%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.30

Company Debt

Total Debt
$4.95M
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$1.64M
Total Cash
$81.09M
Debt to Equity
0.42
Issuance of Debt (TTM)
-$1.64M
Repayment of Debt (TTM)
-$1.64M

Key Statistics

Open
$1.72
Close
-
Volume / Avg.
691.09K / 966.61K
Day Range
$1.68 - $1.78
52 Wk Range
1.33 - 3.10
Market Cap
$242.02M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
52
Short Interest
1.12%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The onl...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy ProQR Therapeutics (PRQR) stock?

A

You can purchase shares of ProQR Therapeutics (NASDAQ:PRQR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are ProQR Therapeutics (PRQR) competitors?

A

There are no as such competitors for ProQR Therapeutics.

Q

What is the forecast, or price target, for ProQR Therapeutics (PRQR) stock?

A

ProQR Therapeutics has a consensus price target of $8.00.

Q

What is the current price for ProQR Therapeutics (PRQR)?

A

The stock price for ProQR Therapeutics (NASDAQ: PRQR) is $1.715 last updated July 14, 2026 at 1:53 PM EDT.

Q

Does ProQR Therapeutics (PRQR) pay a dividend?

A

There are no upcoming dividends for ProQR Therapeutics.

Q

When is ProQR Therapeutics (NASDAQ:PRQR) reporting earnings?

A

ProQR Therapeutics does not have any upcoming earnings scheduled.

Q

Is ProQR Therapeutics (PRQR) going to split?

A

There is no upcoming split for ProQR Therapeutics.

Q

What sector and industry does ProQR Therapeutics (PRQR) operate in?

A

ProQR Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.